Johnson & Johnson finally has some good news to report for its diabetes blockbuster Invokana, after the FDA approved a new cardiovascular outcome claim on its label. The US regulator has approved ...

Invokana (canagliflozin) tablets have been approved as a treatment to be used with diet and exercise, to improve glycemic control in adults with type 2 diabetes. “Invokana is the first diabetes ...